FOXO3 and early-onset autosomal dominant Alzheimer disease: Regulation of FOXO3a contributes to CR-induced prevention of Alzheimer’s disease and spatial memory deterioration in mouse models, and in vitro in human cells, by reducing Aβ peptides through insulin receptor-induced hyperphosphorylation and SIRT1-mediated deacetylation of FOXO3a [456].